Global  

Covaxin generates 'immune response' in animal trial

IndiaTimes Saturday, 12 September 2020
Hyderabad-based vaccine major Bharat Biotech has announced that its Covid-19 vaccine candidate Covaxin, during its testing on animal rhesus macaques, has develop a “robust immune response” to the highly infectious coronavirus, “preventing infection and disease in the primates upon high amounts of exposure to live SARS-CoV-2 virus”.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related news from verified sources

Bharat Biotech’s Covid vaccine generated 'robust immune response' on animals

Hyderabad-based vaccine major Bharat Biotech has announced that its Covid-19 vaccine candidate Covaxin, during its testing on animal rhesus macaques, has develop...
IndiaTimes